Newsletter Subject

New Data on BCMA-Directed Bispecifics in Multiple Myeloma

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Mon, Jul 3, 2023 10:52 PM

Email Preheader Text

Daily Headlines Monday, July 03, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT TH

[MEDPAGE TODAY]( Daily Headlines Monday, July 03, 2023 Today's Top Stories for {NAME} [MEETING COVERAGE]( [New Data on BCMA-Directed Bispecifics in Multiple Myeloma]( [MEETING COVERAGE]( [Testing PD-1 Inhibition With Neoadjuvant Anti-HER2 Therapy in Breast Cancer]( [OPINION]( [There's No Anki Card for Empathy]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [New and Emerging Immunotherapeutic Approaches to Advanced Melanoma]( [PEDIATRICS]( [Medical Spending Higher for Kids Outside Healthy Weight Limits]( [ASCO READING ROOM]( [Naomi Haas, MD, on Triplet Strategies in Metastatic Clear Cell Renal Carcinoma]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [SPECIAL REPORTS]( [What's the Matter With For-Profit Nursing Programs?]( CME SPOTLIGHT [Advancing Post-Transplant CMV Care: Diagnosis and First-Line Treatment]( [MEDICAL JOURNEYS]( [Topical Therapies for Adult Atopic Dermatitis]( [MEDICAL JOURNEYS]( [For Your Patients: Which Topical Treatments Work for Atopic Dermatitis?]( [MEETING COVERAGE]( [PD-1 Inhibition in First-Line Prolongs Survival in Cervical Cancer]( CME SPOTLIGHT [Advancing Post-Transplant CMV Care: Resistant and Refractory CMV Management]( CME SPOTLIGHT [Current Evidence and Guidelines for Treatment Selection for Relapsed/Refractory Multiple Myeloma]( CME SPOTLIGHT [Patient Perspectives in Myelofibrosis Care]( CME SPOTLIGHT [Uncovering the Under-Diagnosed in MDS: The MDS Diagnostic Accelerator Hub]( # Weekly Survey [What Grade Does Walensky Get?]( President Biden commended [outgoing]( CDC Director Rochelle Walensky, MD, MPH, for her 'unwavering focus on the health of every American,' but she has faced a fair amount of criticism for the agency's handling of the pandemic.[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-07-03&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.